Andrea Santamato Selected Research

AN-1792

2/2012	Immunotherapy for Alzheimer's disease: from anti-β-amyloid to tau-based immunization strategies.
12/2011	Anti-β-amyloid immunotherapy for Alzheimer's disease: focus on bapineuzumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrea Santamato Research Topics

Disease

42	Stroke (Strokes) 03/2024 - 01/2010
15	Alzheimer Disease (Alzheimer's Disease) 12/2018 - 12/2007
14	Muscle Spasticity (Spastic) 08/2023 - 10/2010
13	Pain (Aches) 01/2023 - 07/2009
7	Cognitive Dysfunction 03/2023 - 01/2008
6	Dementia (Dementias) 12/2018 - 01/2008
4	Traumatic Brain Injuries (Traumatic Brain Injury) 03/2023 - 06/2021
4	Movement Disorders (Movement Disorder) 09/2017 - 01/2010
3	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 10/2010
3	Multiple Sclerosis 01/2023 - 01/2021
3	Contracture 01/2023 - 10/2009
3	Clubfoot (Talipes Equinovarus) 03/2022 - 11/2017
3	Parkinson Disease (Parkinson's Disease) 01/2010 - 04/2008
2	Polyneuropathies (Polyneuropathy) 04/2022 - 01/2020
2	Muscular Diseases (Myopathy) 04/2022 - 01/2020
2	COVID-19 06/2021 - 01/2021
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 06/2015
2	Cerebral Palsy (Spastic Diplegia) 07/2019 - 01/2014
2	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2018 - 01/2016
2	Shoulder Impingement Syndrome 09/2016 - 07/2009
2	Neuralgia (Stump Neuralgia) 06/2015 - 08/2010
2	Spasm (Spasms) 02/2013 - 10/2010
2	Amyloid Plaque 02/2012 - 01/2010
2	Edema (Dropsy) 02/2012 - 12/2011
2	Meningoencephalitis 02/2012 - 12/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 07/2008 - 12/2007
1	Glioma (Gliomas) 01/2023
1	Critical Illness (Critically Ill) 04/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Congenital Abnormalities (Deformity) 11/2021
1	Hemiplegia (Spastic Hemiplegia) 05/2021
1	Thrombophilia 05/2021
1	Tremor (Tremors) 01/2021
1	Dystonic Disorders (Writer's Cramp) 01/2020
1	Migraine Disorders (Migraine) 01/2020
1	Tendinopathy (Tendonitis) 01/2019
1	Paresis (Hemiparesis) 01/2019
1	Hip Osteoarthritis (Coxarthrosis) 10/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Shoulder Pain 01/2018
1	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2018
1	Osteoarthritis 01/2018
1	Frontotemporal Dementia (Semantic Dementia) 01/2016
1	Muscle Hypertonia 08/2015
1	Piriformis Muscle Syndrome 08/2015
1	Neurogenic Inflammation 06/2015
1	Brain Injuries (Brain Injury) 01/2014

Drug/Important Bio-Agent (IBA)

40	Type A Botulinum Toxins (Botox)FDA Link 03/2024 - 04/2008
25	incobotulinumtoxinA FDA Link 12/2023 - 03/2013
12	Botulinum Toxins (Botulinum Toxin)IBA 01/2023 - 10/2010
6	Amyloid (Amyloid Fibrils)IBA 01/2016 - 10/2010
4	AntibodiesIBA 05/2021 - 02/2012
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 09/2012
3	abobotulinumtoxinA FDA Link 02/2020 - 03/2015
3	AntioxidantsIBA 12/2018 - 01/2008
3	tau Proteins (tau Protein)IBA 01/2016 - 10/2010
3	bapineuzumabIBA 09/2014 - 12/2011
3	ApolipoproteinsIBA 12/2012 - 02/2008
3	Apolipoproteins E (ApoE)IBA 02/2012 - 02/2008
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023 - 06/2015
2	SuspensionsIBA 05/2021 - 01/2021
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2018 - 01/2008
2	Substance PIBA 01/2018 - 08/2015
2	hydromethylthionineIBA 01/2016 - 01/2016
2	Analgesics (Analgesic Drugs)IBA 06/2015 - 06/2012
2	AN-1792IBA 02/2012 - 12/2011
2	VaccinesIBA 02/2012 - 12/2011
2	Peptides (Polypeptides)IBA 02/2012 - 10/2010
1	amsonic acid (DAS)IBA 12/2023
1	fibrin fragment D (D-dimer)IBA 05/2021
1	Vitamin D FDA LinkGeneric 01/2020
1	Phenol (Carbolic Acid)FDA Link 02/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 12/2018
1	Biomarkers (Surrogate Marker)IBA 12/2018
1	Monoclonal AntibodiesIBA 01/2016
1	gosuranemabIBA 01/2016
1	Excipients (Suspending Agents)IBA 01/2016
1	tau-protein kinaseIBA 01/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Antipsychotic Agents (Antipsychotics)IBA 01/2015
1	Humanized Monoclonal AntibodiesIBA 09/2014
1	gantenerumabIBA 09/2014
1	solanezumabIBA 09/2014

Therapy/Procedure

17	Therapeutics 04/2023 - 11/2008
10	Injections 01/2021 - 10/2009
5	Extracorporeal Shockwave Therapy 07/2019 - 02/2013
5	Immunotherapy 01/2016 - 12/2011
2	Nerve Block (Nerve Blocks) 11/2023 - 03/2022
2	Cognitive Training 03/2023 - 03/2023
1	Aftercare (After-Treatment) 08/2023
1	Diathermy 08/2023
1	Exoskeleton Device 04/2023
1	Radiotherapy 01/2023
1	Drug Therapy (Chemotherapy) 01/2023
1	Foot Orthoses 04/2022
1	Neurological Rehabilitation 02/2021
1	Transcranial Direct Current Stimulation 01/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 07/2019
1	Intra-Articular Injections 01/2018